Where expertise, innovation and vision intersect

Medigrowth’s pursuit of excellence blends science, technology, innovation and industry leadership. We partner and collaborate with the brightest minds and like-minded researchers to develop proprietary processes and harness leading global technologies to deliver plant based products. Through strategic partnerships with industry leaders and renowned researchers, Medigrowth draws on world-leading expertise across the entire supply chain.

MEDIGROWTH X KINDRED 

KINDRED is an Australian pet wellness brand founded by a team of animal lovers with expertise across clinical, business, and creative fields. As part of Medigrowth, KINDRED harnesses the potential therapeutic benefits of CBD to support pets suffering from health conditions such as anxiety, chronic pain, and osteoarthritis. With a focus on safety, efficacy, and education, KINDRED provides high-quality medicinal cannabis products while empowering veterinarians with the knowledge to integrate this natural therapy into their practice. Underpinned by compassion, KINDRED supports the RSPCA, helping improve the lives of animals in need.

We’re proud and privileged to ALSO collaborate, partner, share AND learn with the following industry leaders

 

Deakin University has five campuses, five research institutes and eleven strategic research centres. A hive of innovation and world-leading science. Solving global challenges and making a positive impact with world-class R&D capabilities, Deakin University enhances Medigrowth’s expertise and collaboration opportunities across a range of sectors including health, science, engineering, agriculture and technology.

 
 

Pharmout is a specialist medical device and pharmaceutical consultancy. Experts in Good Manufacturing Practice (cGMP), the team at Pharmout have been instrumental in design of the planned Medigrowth Centre of Excellence, ensuring GMP compliance and (QA) Quality Assurance across all sectors of the ‘Hybrid Grow’ design for cultivation, manufacturing, laboratory and research operations.

 
 
 

A subsidiary of Medigrowth Australia, Medigrowth New Zealand will further consolidate the Medigrowth commitment to research and development; ensuring domestic patients have access to pharmaceutical grade plant medicine alternatives.

 
 

Established by the inspirational Lucy Haslam, United in Compassion’s primary mission is: “advocating for patient access to full-spectrum herbal medicinal cannabis extracts and dried herb cannabis; in a manner which is safe, effective, affordable, equitable and favourable for patients, for the dignified relief of suffering.” Medigrowth Australia is committed to support efforts to improve patient access and outcomes.

 

PROUDLY WORKING WITH THE FOLLOWING UNIVERSITIES TO ADVANCE CANNABINOID SCIENCE

 

PARTNER WITH MEDIGROWTH

To learn more about our partnership program, or to enquire about partnering with Medigrowth, reach out to our team.